PRENW's Business Model
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
| Sector & Industry | Healthcare / Medical - Diagnostics & Research |
| Website | https://www.prenetics.com |
| CEO (Chief Executive Officer) | Sheng Wu Yeung |
| Number of Employees | |
| IPO date | July 16, 2021 |
PRENW Latest News
|
|
|
|
|
|
|
|
|
|
| Contact | |
|---|---|
| Country | HK |
| Address | Unit 701-706, K11 Atelier King’s Road |
| City | Quarry Bay |
| State | None |
| Phone | 852 2210 9588 |
| Zip Code | None |
| Other Identifiers | |
| CIK | 0001876431 |
| ISIN | KYG722451146 |
| CUSIP | G72245114 |
| Open | 0.0244 |
| Previous Close | 0.0244 |
| Volume | 260 |
| Average Volume | 44.24 Thou. |
| Day’s Range | 0.021 – 0.0244 |
| 52 Week Range | 0.021-0.0244 |
| MA (50) | 0.02237084 |
| MA (200) | 0.02311817 |
| Market Cap | 278.1 Thou. |
| Shares Out. | 13.24 Mil. |
| Earnings Date | Feb 18, 2026 |
| Beta | |
| Last Dividend | |
| EPS | |
| PE | |
